Suppr超能文献

在乳球菌(Lactococcus lactis)表面生产纤连蛋白结合蛋白 A 可增加体外和体内质粒的转移。

Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo.

机构信息

INRA, UMR1319 Micalis, Jouy-en-Josas, France.

出版信息

PLoS One. 2012;7(9):e44892. doi: 10.1371/journal.pone.0044892. Epub 2012 Sep 27.

Abstract

Lactococci are noninvasive lactic acid bacteria frequently used as protein delivery vectors and, more recently, as DNA delivery vehicles. We previously showed that Lactococcus lactis (LL) expressing the Fibronectin-Binding Protein A of Staphylococcus aureus (LL-FnBPA+) showed higher internalization rates in vitro in Caco-2 cells than the native (wt) lactococci and were able to deliver a eukaryotic Green Fluorescent Protein (GFP) expression plasmid in 1% of human Caco-2 cells. Here, using the bovine beta-lactoglobulin (BLG), one of the major cow's milk allergen, and GFP we characterized the potential of LL-FnBPA+ as an in vivo DNA vaccine delivery vehicle. We first showed that the invasive strain LL-FnBPA+ carrying the plasmid pValac:BLG (LL-FnBPA+ BLG) was more invasive than LL-BLG and showed the same invasivity as LL-FnBPA+. Then we demonstrated that the Caco-2 cells, co-incubated with LL-FnBPA+ BLG produced up to 30 times more BLG than the Caco-2 cells co-incubated with the non invasive LL-BLG. Using two different gene reporters, BLG and GFP, and two different methods of detection, EIA and fluorescence microscopy, we showed in vivo that: i) in order to be effective, LL-FnBPA+ required a pre-coating with Fetal Calf Serum before oral administration; ii) plasmid transfer occurred in enterocytes without regard to the strains used (invasive or not); iii) the use of LL-FnBPA+ increased the number of mice producing BLG, but not the level of BLG produced. We thus confirmed the good potential of invasive recombinant lactic acid bacteria as DNA delivery vector in vivo.

摘要

乳球菌是非侵袭性的乳酸菌,常用于作为蛋白传递载体,最近也被用作 DNA 传递载体。我们之前的研究表明,与天然(wt)乳球菌相比,表达金黄色葡萄球菌纤维连接蛋白结合蛋白 A 的乳球菌(LL-FnBPA+)在体外 Caco-2 细胞中的内化率更高,并且能够将真核绿色荧光蛋白(GFP)表达质粒传递到 1%的人 Caco-2 细胞中。在这里,我们使用牛β-乳球蛋白(BLG),即主要的牛奶过敏原之一,以及 GFP,来研究 LL-FnBPA+作为体内 DNA 疫苗传递载体的潜力。我们首先表明,携带质粒 pValac:BLG 的侵袭性菌株 LL-FnBPA+(LL-FnBPA+ BLG)比 LL-BLG 更具侵袭性,并且与 LL-FnBPA+ 具有相同的侵袭性。然后,我们证明与非侵袭性的 LL-BLG 共孵育的 Caco-2 细胞相比,与 LL-FnBPA+ BLG 共孵育的 Caco-2 细胞产生的 BLG 高达 30 倍。使用两种不同的基因报告子,BLG 和 GFP,以及两种不同的检测方法,EIA 和荧光显微镜,我们在体内证明了:i)为了有效,LL-FnBPA+ 在口服前需要用胎牛血清进行预涂层;ii)质粒转移发生在肠细胞中,与使用的菌株(侵袭性或非侵袭性)无关;iii)使用 LL-FnBPA+ 增加了产生 BLG 的小鼠数量,但不影响 BLG 的产生水平。因此,我们证实了侵袭性重组乳酸菌作为体内 DNA 传递载体的良好潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验